跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Sandostatin - Philippines FDA Drug Approval Details
Approvals
/
Philippines FDA
/
Sandostatin
Approved
STANDARD
Sandostatin
Delpharm Dijon
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
38aea41a3e4ff803
Company
Delpharm Dijon
Type
Standard
Approval Details
Approval Id
38aea41a3e4ff803
Drug Approval Philippines Name
Sandostatin
Product Name
Sandostatin
Registration Number
DR-XY18027
Brand Name
Sandostatin
Generic Name
Octreotide (As Acetate)
Dosage Form
Solution For S.C. Injection / I.V. Infusion
Dosage Strength
100 mcg/mL
Manufacturer
Delpharm Dijon
Importer
Novartis Healthcare Philippines, Inc.
Distributor
Novartis Healthcare Philippines, Inc.
Company Detail Path
/organization/delpharm-dijon
Issuance Date
25 August 2022
Expiry Date
25 August 2027
Pharmacologic Category
Somatostatin Analogue
Classification
Prescription Drug (RX)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
38aea41a3e4ff803
Type
Standard
Back to Philippines FDA Approvals